Janus Henderson Group’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,141,683
| Closed | -$19.9M | – | 2569 |
|
|
2021
Q3 | $19.9M | Sell |
1,141,683
-27,917
| -2% | -$487K | 0.01% | 798 |
|
|
2021
Q2 | $28M | Buy |
1,169,600
+35,828
| +3% | +$859K | 0.01% | 712 |
|
|
2021
Q1 | $29.1M | Buy |
1,133,772
+973,261
| +606% | +$25M | 0.01% | 689 |
|
|
2020
Q4 | $3.05M | Sell |
160,511
-8,498
| -5% | -$161K | ﹤0.01% | 1060 |
|
|
2020
Q3 | $2.13M | Buy |
169,009
+8,233
| +5% | +$104K | ﹤0.01% | 1047 |
|
|
2020
Q2 | $1.94M | Buy |
160,776
+8,469
| +6% | +$102K | ﹤0.01% | 1036 |
|
|
2020
Q1 | $1.17M | Buy |
152,307
+136,392
| +857% | +$1.04M | ﹤0.01% | 1081 |
|
|
2019
Q4 | $283K | Buy |
+15,915
| New | +$283K | ﹤0.01% | 1351 |
|